🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

4 recruiting trials

for Local Recurrence of Malignant Tumor of Prostate

High Dose Rate (HDR) Brachytherapy Salvage After Prostatectomy NCT06982469n/a1 site📍 Pamplona Clinica Universidad de Navarra, Universidad de Navarra · Tests: Brachytherapy Stereotactic Re-irradiation of Local Recurrences of Prostate Cancer After Radiotherapy NCT06201078Phase 21 site📍 Gliwice Maria Sklodowska-Curie National Research Institute of Oncol… · Tests: Stereotactic Body Radiotherapy Non-inferiority Study Comparing Salvage Pelvic Radiotherapy in 25 Fractions (62.5 Gy/25) Versus 20 Fractions (52.5 Gy/20) for Recurrent Prostate Cancer After Surgery. NCT07483658NA4 sites📍 Gatineau📍 Montreal📍 Montreal CHU de Quebec-Universite Laval · Tests: Standard Fractionation Post-Operative Salvage Radiotherapy (25 fractions), Hypofractionated Post-Operative Salvage Radi… Irreversible Electroporation (IRE) for Treating Recurrent Pelvic Tumors (PELFIRE Study) NCT07782164n/a1 site📍 Amsterdam Amsterdam UMC, location VUmc · Tests: Irreversible electroporation
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy